Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VIBATIV (Telavancin Hydrochloride) Pregnancy Exposure Registry

NCT01130324 is registered in ClinicalTrials.gov with Cumberland Pharmaceuticals as lead sponsor.

NCT NCT01130324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01130324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VIBATIV (Telavancin Hydrochloride) Pregnancy Exposure Registry
Lead sponsor
Cumberland Pharmaceuticals
Phase
Observational
Overall status
Withdrawn
Start date
November 30, 2009
Completion date
October 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy